XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Cash Flows From Operating Activities    
Net income (loss) $ 11,694 $ (17,221)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization 47,408 67,106
Gain on sale of property (15,696) 0
Amortization of non-cash items within interest expense 2,238 14,593
Amortization of acquired above- and below-market leases, net (703) (1,784)
Amortization of acquired below-market ground leases 1,958 1,958
Straight-lining of rental revenue (556) (2,595)
Equity based compensation 4,374 4,460
Increase (decrease) in cash flows due to changes in operating assets and liabilities:    
Security deposits 10,184 (478)
Tenant and other receivables 258 847
Deferred leasing costs (4,498) (14,525)
Prepaid expenses and other assets 34,915 27,018
Accounts payable and accrued expenses (6,804) (12,661)
Deferred revenue and other liabilities 1,591 975
Net cash provided by operating activities 86,363 67,693
Cash Flows From Investing Activities    
Net proceeds from sale of property 39,137 0
Development costs (12) (31)
Additions to building and improvements (41,756) (34,945)
Net cash used in investing activities (2,631) (34,976)
Cash Flows From Financing Activities    
Repayment of mortgage notes payable (2,142) (2,092)
Contributions from consolidated joint ventures 0 224
Repurchases of common units (5,694) (12,001)
Distributions (9,743) (10,819)
Net cash used in financing activities (17,579) (24,688)
Net increase (decrease) in cash and cash equivalents and restricted cash 66,153 8,029
Cash and cash equivalents and restricted cash—beginning of period 314,678 474,638
Cash and cash equivalents and restricted cash—end of period 380,831 482,667
Reconciliation of Cash and Cash Equivalents and Restricted Cash:    
Cash and cash equivalents at beginning of period 264,434 423,695
Restricted cash at beginning of period 50,244 50,943
Cash and cash equivalents at end of period 272,648 429,716
Restricted cash at end of period 108,183 52,951
Cash and cash equivalents and restricted cash 380,831 482,667
Supplemental disclosures of cash flow information:    
Cash paid for interest 23,006 19,655
Cash paid for income taxes 283 93
Non-cash investing and financing activities:    
Building and improvements included in accounts payable and accrued expenses 39,982 57,072
Write-off of fully depreciated assets 847 4,744
Derivative instruments at fair values included in prepaid expenses and other assets 12,446 45
Derivative instruments at fair values included in accounts payable and accrued expenses 2,171 13,290
Conversion of operating partnership units to ESRT partner's capital $ 2,544 $ 1,497